School of Medicine

Nanoparticles attached to fibers in a blood clotNano-sized particles developed at the School of Medicine offer hope of replacing numerous medical tests, scans, or surgeries with a simple injection. The tiny spheres can travel through the bloodstream deep into the body to locate and highlight tumors undetectable by typical methods. While at the tumor site, the nanoparticles can deliver therapeutic agents to destroy the tumor.

The professor of anatomy and neurobiology and of radiology is a leader in research into techniques for rehabilitating the brain after strokes.

“We were able to associate risk of death with the characteristics of the patients’ beta-adrenergic receptor genes,” says study co-author Howard McLeod.

Interferon — a critical protein that mediates the body’s defense against a wide variety of infectious agents and tumors — may soon have greater therapeutic value as the result of a new study by researchers at the School of Medicine.

A monoclonal antibody that can effectively treat mice infected with West Nile virus has an intriguing secret: Contrary to scientists’ expectations, it does not block the virus’s ability to attach to host cells. Instead, the antibody somehow stops the infectious process at a later point.

Survival of heart attack and unstable angina patients placed on beta-blocker therapy corresponds to specific variations in their genes, according to a study by researchers at the School of Medicine and the Mid America Heart Institute in Kansas City.

“This is the largest systematic trial of AIDS treatment to ever be conducted on a multinational stage,” David B. Clifford says. More medical news

High-caliber cancer services are now more proximate to the people of St. Charles and its surrounding communities.

The findings provide a new understanding of how individual cells find their niche during organ development.

Photo by Robert BostonGuests socialize during the Sept. 16 opening celebration of the Farrell Learning and Teaching Center on the Medical Campus.